Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD4-dependent and CD4-independent HIV-2: consequences for neutralization.

Elaine R Thomas1, Christine Shotton, Robin A Weiss

  • 1The Wohl Virion Centre, Windeyer Institute of Medical Sciences, University College London, London W1T 4JF, UK.

AIDS (London, England)
|January 31, 2003
PubMed
Summary

Human Immunodeficiency Virus type 2 (HIV-2) isolates that infect cells without CD4 are more vulnerable to antibody neutralization. This increased sensitivity may explain HIV-2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial" [J. Clin. Virol. 155C (2022) 105248].

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2025
Same author

Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1.

bioRxiv : the preprint server for biology·2024
Same author

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.

The Lancet. Rheumatology·2024
Same author

Implications of the 375W mutation for HIV-1 tropism and vaccine development.

Journal of virology·2024
Same author

The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV.

mBio·2023
Same author

Curbside particulate matter and susceptibility to SARS-CoV-2 infection.

The journal of allergy and clinical immunology. Global·2023

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human Immunodeficiency Virus type 2 (HIV-2) exhibits lower pathogenicity than HIV-1.
  • Unlike HIV-1, many HIV-2 isolates can infect cells independently of the CD4 receptor.

Purpose of the Study:

  • To compare the antibody-mediated neutralization sensitivity of CD4-dependent and CD4-independent HIV-2 isolates.
  • To investigate the role of cellular CD4 in HIV-2 neutralization resistance.

Main Methods:

  • Assessed neutralization sensitivity of CD4-dependent and -independent HIV-2 molecular clones and primary isolates using HIV-2-positive sera.
  • Employed monoclonal antibodies targeting viral envelope epitopes to identify neutralization determinants.
  • Analyzed antibody binding to viral envelopes via ELISA and flow cytometry.

Related Experiment Videos

Main Results:

  • CD4-independent HIV-2 isolates, including primary strains, demonstrated significantly higher sensitivity to antibody neutralization compared to CD4-dependent isolates.
  • Inducing CD4 independence in a CD4-dependent isolate increased its neutralization sensitivity.
  • Neutralization sensitivity was not epitope-specific, though certain conformation-dependent antibodies enhanced the effect.

Conclusions:

  • HIV-2 isolates employing CD4-independent infection pathways are more susceptible to antibody neutralization.
  • Cellular CD4 appears to confer protection against antibody-mediated neutralization in HIV-2.
  • This heightened neutralization sensitivity may contribute to lower viral loads and slower disease progression in HIV-2-infected individuals.